Canada has the highest rate of multiple sclerosis (MS) in the world, with an estimated 1 in 340 Canadians living with the disease. Currently, the exact cause of MS and how to prevent it are still a mystery, and this week top MS researchers from around the globe will gather in London to share the latest research breakthroughs with their peers and the public.
As part of the J. Allyn Taylor International Prize in Medicine Symposium hosted by Robarts Research Institute at Western’s Schulich School of Medicine & Dentistry, experts in the fields of diagnosis, treatment and prevention of MS will present their work and will join in an engaging panel discussion moderated by André Picard, health columnist with The Globe and Mail.
Members of the media are invited to the panel discussion, A Brighter Future: Frontiers in Multiple Sclerosis Research and Treatment and to the afternoon sessions which will include an update on MS research in London, Ontario, and the keynote lecture from V. Wee Yong, PhD, the 2017 J. Allyn Taylor International Prize in Medicine recipient.
J. Allyn Taylor International Prize in Medicine Symposium
Sponsored by Biogen
Wednesday, November 15
Auditorium A, University Hospital, London Health Sciences Centre
1 – 2 p.m.
Panel Discussion – A Brighter Future: Frontiers in Multiple Sclerosis Research and Treatment
Sponsored by Sanofi Genzyme
Brenda Banwell, MD, FAAP, FRCPC, FAAN
Chief of the Division of Neurology, Children’s Hospital of Philadelphia; Grace R. Loeb Endowed Chair in Neurosciences
Alan J. Thompson, MD, FMedSci, FRCP, FRCPI
Consultant Neurologist, National Hospital for Neurology and Neurosurgery (NHNN), Queen Square, London, UK
Jiwon Oh, MD, PhD
Assistant Professor, Department of Medicine, University of Toronto; Scientist, Keenan Research Centre of the Li Ka Shing Knowledge Institute of St. Michael’s Hospital; Neurologist, St. Michael’s Hospital
Jennifer Gommerman, PhD
Associate Professor, Immunology, University of Toronto
Ravi Menon, PhD
Professor, Schulich School of Medicine & Dentistry and Scientist, Robarts Research Institute, Western University; Canada Research Chair in Functional and Molecular Imaging
Sarah Morrow, MD, FRCPC, MS
Associate Professor, Schulich Medicine & Dentistry, Western University; Neurologist, London Health Sciences Centre; Scientist, Lawson Health Research Institute
Steven Kerfoot, PhD
Associate Professor, Schulich Medicine & Dentistry, Western University
V. Wee Yong, PhD, 2017 J. Allyn Taylor International Prize in Medicine Recipient
Professor, Hotchkiss Brain Institute, University of Calgary; Co-director, Multiple Sclerosis Program, Hotchkiss Brain Institute; Canada Research Chair in Neuroimmunology
2 – 2:30 p.m.
Media availability for interviews
London MS Update
Ravi Menon, PhD, Sarah Morrow, MD, FRCPC, MS and Steven Kerfoot, PhD
Keynote Lecture – V. Wee Yong, PhD, 2017 J. Allyn Taylor International Prize in Medicine Recipient
Sponsored by EMD Serono
Bench to Bedside: The science of translational medicine in MS
Please contact Crystal Mackay to confirm your attendance and arrange for interviews. Panellist bios available upon request.
MEDIA CONTACT: Crystal Mackay, Media Relations Officer, Schulich School of Medicine & Dentistry, Western University, t. 519.661.2111 ext. 80387, c. 519.777.1573, email@example.com
Western University delivers an academic experience second to none. Since 1878, The Western Experience has combined academic excellence with life-long opportunities for intellectual, social and cultural growth in order to better serve our communities. Our research excellence expands knowledge and drives discovery with real-world application. Western attracts individuals with a broad worldview, seeking to study, influence and lead in the international community.
ABOUT THE SCHULICH SCHOOL OF MEDICINE & DENTISTRY
The Schulich School of Medicine & Dentistry at Western University is one of Canada’s preeminent medical and dental schools. Established in 1881, it was one of the founding schools of Western University and is known for being the birthplace of family medicine in Canada. For more than 130 years, the School has demonstrated a commitment to academic excellence and a passion for scientific discovery.